Pfizer Inc’s new CEO on Tuesday outlined plans to reduce the company’s spending and work force and focus more sharply on promising drugs as it faces slowing sales of some of its blockbuster medicines.
In the latest quarter, a tax benefit and rising sales from products gained in its Wyeth acquisition helped Pfizer just beat Wall Street expectations. Profits nearly quadrupled, compared with a 2009 quarter hurt by big restructuring charges, but overall sales are slowing and the company said its revenue will drop next year.
Still, shares rose more than 5 percent on Tuesday as chief executive Ian Read announced a US$5 billion stock buyback and an ambitious overhaul of operations that will cut jobs and research spending while aiming to boost research productivity and emerging market sales. Pfizer will cut its 110,600-person work force by up to 5 percent.
The strategy outlined by Read includes many elements being tested across the pharmaceutical industry and tried by his predecessor, Jeffrey Kindler. He was ousted by Pfizer’s board unexpectedly on Dec. 6 after four years of languishing share prices and several failures of promising drugs in late testing, including a successor to cholesterol fighter Lipitor, the world’s top-selling drug.
“A lot of what we are doing individually you can see in different companies,” Read said, citing plans to increase external collaborations and prune the research portfolio to diseases with the best medical and financial payoffs. “I think we have a holistic game plan that is functioning as a total engine” to drive productivity.
The world’s largest drugmaker by revenue, Pfizer said fourth-quarter net income was US$2.89 billion, or US$0.36 per share, up from US$767 million, or US$0.10 a share, a year ago.
Adjusted net income was down 1 percent, at US$3.77 billion, or US$0.47 per share. Numerous one-time items brought a total gain of US$0.11 per share, including a US$2 billion benefit from a tax settlement, legal costs, and a host of restructuring and other expenses from Pfizer’s US$68 billion purchase of Wyeth in October 2009.
Revenue totaled US$17.56 billion, up 6 percent, as a dip in US sales was more than offset by higher sales elsewhere. For all of last year, Pfizer reported a 4 percent decline in net income, to US$8.26 billion, or US$1.02 per share. Revenue totaled US$67.81 billion, up 36 percent, thanks to US$18.1 billion from sales of Wyeth products.
Pfizer gave its first financial forecast for this year, for earnings per share of US$2.16 to US$2.26, excluding just over US$1 in one-time items. It expects flat revenue, at about US$67 billion.
Pfizer plans to cut research spending next year by US$1.5 billion, to about US$8.25 billion. The research cuts will come mainly from phasing out work in four disease areas: allergy and respiratory, urology, general medicine and tissue repair.
DEVELOPING TALENT: The electronics contractor is looking to recruit people to work in core tech fields and emerging industries like electric cars and robotics Hon Hai Precision Industry Co (鴻海精密), the world’s largest contract electronics maker, has launched a recruitment drive, offering a monthly salary of no less than NT$45,000 (US$1,485) to university graduates. For those with a master’s degree, the starting pay would be NT$52,000 per month at the minimum, while doctorate degree holders would receive at least NT$60,000 a month, Hon Hai said a statement issued early this week. The latest recruitment drive is aimed at attracting talent in core technology fields — artificial intelligence, semiconductors and next-generation mobile communications — and emerging industries — electric vehicles, digital healthcare and robotics, the
NEW CONSIDERATIONS: An airline manager said the idea is tempting, as demand for air cargo is strong, but issues such as training loaders would need to be addressed Taiwanese airlines might repurpose passenger jets to carry cargo in their cabins to offset lost revenue amid the COVID-19 pandemic. Airlines are considering applying to the Civil Aeronautics Administration (CAA) for permission to transport cargo in passenger cabins after StarLux Airlines Co (星宇航空) last month became the first among the nation’s airlines to offer cargo-only flights using the normal cargo holds of its three Airbus SE A321neo passenger jets. “We are considering whether to increase our capacity by putting cargo on passenger seats,” Starlux spokesman Nieh Kuo-wei (聶國維) told the Taipei Times by telephone. “The advantage is that we can improve revenue,
GLOBAL CUTS: CEO Warren East said the firm’s focus was on strengthening financial resilience, so it would likely reduce salary costs by at least 10% this year Rolls-Royce Holdings PLC is scrapping its targets and final dividend to shore up its finances as the British aero-engine maker’s customers around the world ground planes due to the COVID-19 pandemic. Rolls-Royce, one of Britain’s most historic industrial names, which before the pandemic struck was trying to emerge from a multiyear turnaround plan, has suspended its dividend for the first time since 1987. The company’s engines power Airbus SE and Boeing Co’s widebody jets, but more than 60 percent of that fleet is now grounded, according to aviation data provider Cirium. Rolls-Royce is paid by airlines based on how many hours they fly. Over
PAINFUL CONTRACTION: Passenger loads in February on flights between Taiwan and China, Hong Kong and Macau fell by more than 90 percent compared with December Even with more than NT$450 billion (US$14.85 billion) in financial aid from the Executive Yuan’s expanded relief package, local tourism-related businesses are unlikely to rebound from the COVID-19 pandemic any time soon, a central bank report released last month said. The NT$1.05 trillion relief package includes NT$472 billion in financial assistance for tourism and transportation sectors, such as airlines, hotels, travel agencies, taxis and tour buses. However, a March 20 central bank report said that the effects of the COVID-19 pandemic on global and domestic economies are far greater than that of the 2002-2003 SARS epidemic, despite any benefits from delayed purchases